Dianabol (Methandienone) Injection - Genesis | 10 ml | 100 mg/ml represents a potent, rapid-acting anabolic formulation engineered for advanced bodybuilders seeking rapid hypertrophy and superior strength elevation. Unlike conventional oral tablets, this formulation delivers pure methandienone suspended in an oil-based injectable medium. By entering circulation directly via intramuscular administration, it reduces the immediate first-pass hepatic stress typical of oral 17-alpha-alkylated compounds, while preserving rapid biological absorption.
Methandienone operates primarily by binding avidly to the androgen receptor (AR), triggering a massive up-regulation of cellular protein synthesis and glycogenolysis. It markedly enhances nitrogen retention within skeletal muscle tissue, ensuring a prolonged, deep intracellular anabolic state. Athletes utilizing this injectable format frequently observe pronounced strength breakthroughs, intense muscular pumps, and significant lean mass accrual within the first 7 to 10 days of administration.
Due to the pharmacokinetic profile of suspended or dissolved methandienone, regular dosing maintains stable blood serum concentrations. As a premier Methandienone injection option, typical athlete protocols range from 30 mg to 50 mg every other day (EOD) or 50 mg daily for seasoned competitors. Cycles should generally be limited to 6 to 8 weeks to avoid excessive strain on biological markers.
Dianabol by Genesis is typically deployed as an intensive kickstart during mass-building cycles. It pairs synergistically with long-estered base compounds such as Testosterone Enanthate, Testosterone Cypionate, and Nandrolone Decanoate (Deca-Durabolin). By elevating free anabolic signaling immediately, it bridges the latency period required for long esters to reach steady-state concentration. For lean mass protocols, stacking with Trenbolone Enanthate yields dense, dramatic size gains, provided estrogen management is strictly observed.
Because Methandienone aromatizes into 17-alpha-methylestradiol—a highly active form of estrogen—the introduction of an Aromatase Inhibitor (such as Anastrozole or Exemestane) is mandatory to control water retention and prevent gynecomastia. Although injectable methandienone exhibits lower acute hepatic toxicity than oral pills, regular monitoring of transaminases (ALT/AST), blood pressure, and lipid profiles is advised. Complete Post-Cycle Therapy (PCT) utilizing Clomiphene Citrate (Clomid) and Tamoxifen Citrate (Nolvadex), combined with an HCG bridge, must commence immediately following cycle cessation to restore endogenous luteinizing hormone (LH) and testosterone synthesis.
Injectable Methandienone avoids immediate hepatic first-pass metabolism, offering smoother bioavailability and reducing acute gastrointestinal distress compared to tablets, while offering a slightly extended active half-life.
Yes. Methandienone converts readily into 17-alpha-methylestradiol, an estrogen isomer that triggers fluid retention and gynecomastia. Running an AI like Arimidex or Aromasin is strongly advised from day one.
Due to its rapid cellular signaling and enhanced glycogen retention, noticeable increases in muscular fullness, workout recovery, and explosive strength are commonly reported within 3 to 7 days of the first injection.
